Updates
News
Latest news posts
Series C round co-led by R42 Group and Atomico, and joined by new/current investors; Financing to advance expanding rare disease pipeline U.S. FDA has cleared its investigational new drug (IND) application to advance HLX-1502 in Phase 2 clinical trial in NF1; Healx to initiate Phase 2 clinical trial by end of year Healx, co-founded by … Continued
It is with a heavy heart that we inform you of the untimely and unexpected passing of our esteemed colleague and friend, Dr. Neil T. Thompson. Neil previously served as Chief Scientific Officer at Healx and was the current Chairman of our Scientific Advisory Board. His profound contributions to our organisation and the broader scientific … Continued